Infosys Public Services, a U.S.-based subsidiary of Infosys, is to set up a testing center of excellence (COE) for Prime Therapeutics as part of a three-year contract.
Prime Therapeutics selected Infosys Public Services for its health care and pharmacy benefit management expertise, the company said in a release.
Prime Therapeutics is a pharmacy benefit manager headquartered in Minnesota.
“This agreement will allow us to help the company sharpen its focus on providing better care and services to their members,” said Eric Paternoster, President and Chief Executive Officer at Infosys Public Services.
Infosys Public Services will consolidate and standardise Prime Therapeutics’ quality assurance (QA) and testing services, currently provided by multiple service providers.
“Transforming our testing and QA services will help us achieve that and better meet the needs of health plans, employers, and government programmes,” said Jim Graham, Vice President Application Development, Prime Therapeutics.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.